Michela Palmieri

High Impact

RTDA

University of Arkansas for Medical Sciences

faculty

35 h-index 85 pubs 10,595 cited

Research Areas

Bone health and treatments Metabolism and Genetic Disorders Neurological disorders and treatments Cancer Treatment and Pharmacology Multiple Myeloma Research and Treatments Molecular Biology Techniques and Applications Health and Medical Research Impacts Immune Response and Inflammation

Links

ORCID Lab Website Research Group

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Michela Palmieri's research investigates mechanisms of bone loss and resorption, with recent work focusing on the role of osteocytes and oxidized phospholipids in age-associated bone loss in mice. Palmieri also studies signaling axes that promote chemoresistance in multiple myeloma and explores autophagic imbalances in Mecp2-deficient models relevant to Rett syndrome.

Palmieri has a strong publication record, with 85 total publications and over 10,595 citations, resulting in an h-index of 35. This scholarship has led to a designation as a high-impact researcher. Palmieri leads a research group and maintains an active lab website. Key collaborators include Elena Ambrogini, Teenamol E. Joseph, Charles A. O’Brien, and Horacio Gómez-Acevedo, all from the University of Arkansas for Medical Sciences, with whom Palmieri has co-authored multiple publications.

Metrics

h-index: 35
Publications: 85
Citations: 10,595

Selected Publications

Deletion of the scavenger receptor Scarb1 in osteoblast progenitors and myeloid cells does not affect bone mass (2025) DOI
Deletion of the scavenger receptor <i>Scarb1</i> in osteoblast progenitors and myeloid cells does not affect bone mass (2025) DOI
Plasma levels of anti phosphocholine IgM antibodies are negatively correlated with bone mineral density in humans (2025) DOI
Senolytics deplete senescent osteocytes and improve bone health in metastatic breast cancer (2024) DOI
Single-cell Transcriptome Analysis Identifies Senescent Osteocytes as Contributors to Bone Destruction in Breast Cancer Metastasis (2024) DOI
A NOTCH3-CXCL12-driven myeloma-tumor niche signaling axis promotes chemoresistance in multiple myeloma (2024) DOI
OR27-02 The Bone Anabolic Effect Of An Antibody Blocking Oxidized Phospholipids Is Associated With An Increase In Wnt10b In Osteoblasts. (2023) DOI
Retraction notice to “Deletion of the scavenger receptor Scarb1 in myeloid cells does not affect bone mass” [Bone 170(2023) 116702] (2023) DOI
Reduced osteoprotegerin expression by osteocytes may contribute to rebound resorption after denosumab discontinuation (2023) DOI
RETRACTED: Deletion of the scavenger receptor Scarb1 in myeloid cells does not affect bone mass (2023) DOI
Deletion of the Scavenger Receptor Scarb1 in Myeloid Cells Does Not Affect Bone Mass (2022) DOI
Deletion of the scavenger receptor Scarb1 in osteoblast progenitors does not affect bone mass (2022) DOI
Neutralization of oxidized phospholipids attenuates age‐associated bone loss in mice (2021) DOI